New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3

In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).

Dementia Prevention in Primary Care – A Mini Audit

This activity will focus on dementia prevention in primary care and will involve:

Sending a link to a standardised questionnaire (CogDrisk) aimed at calculating a risk profile and identifying modifiable risk factors for dementia to all your patients between age 45-65
Invite those who would like to discuss the results and further possible action to make an appointment to see you for a discussion and possibly to develop a plan to address the risk factors identified
You then document 5 – 10 of these consultations and resulting clinical actions using the structured audit report provided within this activity
Healthed will submit this on your behalf to the RACGP or ACRRM